MX9605030A - Terapia de combinacion antiemetica usando antagonistas de receptor nk-1. - Google Patents
Terapia de combinacion antiemetica usando antagonistas de receptor nk-1.Info
- Publication number
- MX9605030A MX9605030A MX9605030A MX9605030A MX9605030A MX 9605030 A MX9605030 A MX 9605030A MX 9605030 A MX9605030 A MX 9605030A MX 9605030 A MX9605030 A MX 9605030A MX 9605030 A MX9605030 A MX 9605030A
- Authority
- MX
- Mexico
- Prior art keywords
- combination
- receptor antagonists
- antiemetic therapy
- antiemetic
- therapy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Otolaryngology (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La presente invencion se refiere a procedimientos de tratamiento o prevencion de la emesis en mamíferos, incluyendo a humanos, usando un antagonista de NK-1 en combinacion con uno o más agentes activos diferentes seleccionados entre (a) un glucocorticoide o corticoesteroide, (b) una benzodiacepina, (c) metaclopramida y (d) un depurador molecular intracelular.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US572895P | 1995-10-20 | 1995-10-20 | |
US005728 | 1995-10-20 |
Publications (2)
Publication Number | Publication Date |
---|---|
MX9605030A true MX9605030A (es) | 1997-09-30 |
MXPA96005030A MXPA96005030A (es) | 1998-07-03 |
Family
ID=
Also Published As
Publication number | Publication date |
---|---|
AU700841B2 (en) | 1999-01-14 |
NZ299606A (en) | 2000-07-28 |
EP0769300A2 (en) | 1997-04-23 |
AU7027996A (en) | 1997-05-15 |
ZA968790B (en) | 1998-04-20 |
CA2188227C (en) | 2000-08-08 |
CA2188227A1 (en) | 1997-04-21 |
IL119418A (en) | 2001-07-24 |
JPH09110721A (ja) | 1997-04-28 |
EP0769300A3 (en) | 1999-11-24 |
IL119418A0 (en) | 1997-01-10 |
TW458774B (en) | 2001-10-11 |
CN1151893A (zh) | 1997-06-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
YU59098A (sh) | Derivati spiro-piperidina, postupak njihovog dobijanja, njihova upotreba u proizvodnji leka korisnog za lečenje ili prevenciju bolova, upalnih procesa, migrene, povraćanja i postherpetične neuralgije i farmaceutski sastav koji ih sadrži | |
MX9703186A (es) | Antagonistas del receptor del neuropeptido y de indolilo. | |
MXPA99001870A (es) | Antagonistas del receptor de taquicinina,no peptidicos. | |
MY116002A (en) | Nk-1 receptor antagonists and 5ht3 receptor antagonists for the treatment of emesis | |
MY131434A (en) | Angiotensin ii antagonists | |
DE69528823D1 (en) | Morpholinwirkstoffvorläufer als tachykininreceptorantagonisten | |
WO1996019458A3 (en) | Steroid receptor modulator compounds and methods | |
AU1753699A (en) | Application of vasopressin antagonists for treating disturbances or illnesses ofthe inner ear | |
IL142921A0 (en) | USES FOR Eph RECEPTOR ANTAGONISTS AND AGONISTS TO TREAT VASCULAR DISORDERS | |
MX9603259A (es) | Tratamiento de glaucoma normotensivo con antagonistas de angiotensina ii. | |
MY115310A (en) | Substance p antagonists for the treatment of emesis | |
PL316754A1 (en) | Insecticidal mixtures of artificial fertilisers | |
NZ333723A (en) | A synergistic combination of an insulin resistance improving agent and an angiotensin II receptor antagonist or an angiotensin converting enzyme inhibitor | |
CA2328411A1 (en) | Glucocorticoid receptor antagonists for the treatment of dementia | |
GB9305718D0 (en) | Medicaments | |
BR0311898A (pt) | Tratamento de associação para depressão e ansiedade com antagonistas de nk1 e nk3 | |
AU1667500A (en) | N-(2-phenyl-4-piperidinybutyl)-5,6,7,8-tetrahydro-1-naphthal necarboxamides and their use as neurokinin 1 (nk1) and/or neurokinin 2 (nk2) receptor antagonists | |
ATE381533T1 (de) | Pharmazeutisch wirksame verbindungen und methoden zu ihrer anwendung | |
WO1999038532A3 (en) | Methods for the prevention and treatment of fibrosis and sclerosis | |
BG105761A (en) | Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents | |
GR3023021T3 (en) | Synergising association having an antagonist effect on nk1 and nk2 receptors. | |
BG105962A (en) | Use of saredutant and the pharmaceutically acceptable salts thereof to produce medicaments used to treat or prevent mood disorders, adjustment disorders or mixed anxiety-depression disorders | |
EP1166783A3 (en) | Tetrahydrobenz[CD]indole-6-carboxamides for treating sexual dysfunction | |
MX9605030A (es) | Terapia de combinacion antiemetica usando antagonistas de receptor nk-1. | |
ATE282417T1 (de) | Die verwendung von nk-1 rezeptor antagonisten für die behandlung von bewegungsstörungen |